SCHEMBL2575260

SCHEMBL2575260

CC(C)OCNc1nccc(N2CCNCC2)n1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 15/20 0.71
HRH3 Q9Y5N1 5/20 0.59
CXCR4 P61073 1/20 0.46
OGA O60502 3/20 0.45
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
SLC6A2 P23975 1/20 0.44
HRH2 P25021 1/20 0.44
HTR1D P28221 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTR7 P34969 1/20 0.44
HTR2B P41595 1/20 0.44
HTR5A P47898 1/20 0.44
HTR6 P50406 1/20 0.44
SLC6A3 Q01959 1/20 0.44
TMEM97 Q5BJF2 1/20 0.44
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1588650 0.83 HRH4 (1.00) HRH4HRH3CXCR4OGAADRA2B
SCHEMBL605069 0.80 HRH4 (0.68) HRH4HRH3OGA
SCHEMBL605070 0.80 HRH4 (0.68) HRH4HRH3OGA
SCHEMBL1588619 0.80 HRH4 (0.67) HRH4HRH3CXCR4OGAADRA2B
SCHEMBL602710 0.79 HRH4 (0.76) HRH4HRH3
SCHEMBL602711 0.79 HRH4 (0.76) HRH4HRH3
SCHEMBL859700 0.79 HRH4 (0.72) HRH4HRH3CXCR4OGA
SCHEMBL29935697 0.79 HRH4 (0.72) HRH4HRH3CXCR4OGA
SCHEMBL846581 0.78 HRH4 (0.74) HRH4HRH3CXCR4OGAADRA2B
SCHEMBL1588024 0.78 HRH4 (1.00) HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2382013-A1 SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS. INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2011-11-02 EP disclosed
WO-2010072829-A1 SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS. INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2010-07-01 WO disclosed